Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Pediatrics. 2017 Nov;140(5):e20170508. doi: 10.1542/peds.2017-0508

TABLE 2.

Association of Subject Characteristics With the Primary and Restrictive Outcomes Regardless of Intervention Group Adjusted for Clustering by Recruitment Center

Primary Restrictive
Outcomea Outcome
Age, y, %
 <15 44.2 11.1
 ≥15 29.0 5.4
P < .001 P < .001
Sex, %
 Male 33.2 7.1
 Female 39.0 8.8
P = .01 P = .11
Race and ethnicity, %
 Non-Hispanic white 36.3 7.5
 Non-Hispanic African American 37.0 8.5
 Hispanic 35.2 8.5
 Other 35.3 6.8
P = .80 P = .94
BMI, %
 Normal 37.8 7.9
 Overweight or obese 34.3 8.2
P = .14 P = .21
Passed out or nearly passed out from shot or blood draw in
 the past 5 y, %
 No 35.4 7.5
 Yes 47.8 15.1
P = .009 P = .02
Hunger or thirst at the time of enrollment, %
 Not at all or a little bit 35.3 7.2
 Very 39.2 10.9
P = .13 P = .02
Tired at the time of enrollment, %
 Not at all or a little bit 35.6 7.8
 Very 40.1 13.9
P = .36 P = .07
Prevaccination anxiety, %
 None or slight 33.9 6.3
 Mild, moderate, or severe 40.8 11.5
P = .004 P < .001
No. of injectable vaccines,​b %
 1 30.6 5.2
 >1 43.7 11.8
P < .001 P < .001
Receipt of HPV vaccine, %
 No 33.8 7.3
 Yes 38.3 8.5
P = .02 P = .11
Pain intensity after vaccination, %
 0–1 31.9 5.1
 2–5 62.0 26.1
P < .001 P < .001
a

The primary outcome is “a little bit” or more in response to any of the 12 items on the presyncope instrument. The restrictive outcome is “somewhat” or more in response to any of the 12 items on the presyncope instrument.

b

Including intramuscularly and subcutaneously administered vaccines.